| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |